Re: OT Question. Grampa?
Aren't you forgetting about the possibility that NVAX goes much lower? This would increase your cost to roll out the Puts.
I think the biggest risk between now and February 18 is that Novavax does NOT file their EUA request by Janaury 31 as widely expected. If that happen, NVAX is surely gong to take another hit.
I am somewhat surprised that the Cowen rating did not put some momentum into NVAX. I guess there is just too many forces working against the COVID stocks right now. Another court ruling invalidating the vaccine mandate for Federal workers certainly did not help. Novavax needs to forget about an omicron specific vaccine and focus on a bi-valent vaccine to jump ahead of the mRNA vaccines.